Holen Sie sich die Stockscreener-App
13.02
2.62%
-0.35
Finanzdaten der Cadrenal Therapeutics Inc-Aktie (CVKD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
4.93%
3.7343
|
3.928 | 2.46 | 2.4666 | 1.7556 |
| Operating Income/Loss |
4.93%
-3.7343
|
-3.928 | -2.46 | -2.4666 | -1.7556 |
| Nonoperating Income/Loss |
18.88%
0.067
|
0.0826 | 0.0521 | 0.0736 | 0.0923 |
| Income/Loss From Continuing Operations Before Tax |
4.63%
-3.6673
|
-3.8454 | -2.4078 | -2.393 | -1.6633 |
| Income/Loss From Continuing Operations After Tax |
4.63%
-3.6673
|
-3.8454 | -2.4078 | -2.393 | -1.6633 |
|
Net Income/Loss
|
4.63%
-3.6673
|
-3.8454 | -2.4078 | -2.393 | -1.6633 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
6.38%
1.9616
|
1.8441 | 1.104 | 16.01 | 16.01 |
| Diluted Average Shares |
6.38%
1.9616
|
1.8441 | 1.104 | 16.01 | 16.01 |
| Basic Earnings Per Share |
10.53%
-1.87
|
-2.09 | -2.18 | -0.15 | -0.10 |
| Diluted Earnings Per Share |
10.53%
-1.87
|
-2.09 | -2.18 | -0.15 | -0.10 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.68%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):